The ability of hematopoietic stem cells (HSCs) to undergo self-renewal is partly regulated by external signals originating from the stem cell niche. Our previous studies using HSCs obtained from the fetal liver of mice deficient for the calcium-sensing receptor (CaR) have shown the crucial role of this receptor in HSC lodgment and engraftment in the bone marrow (BM) endosteal niche. Using a CaR agonist, Cinacalcet, we assessed the effects of stimulating the CaR on the function of murine HSCs. Our results demonstrate that CaR stimulation increases primitive hematopoietic cell activity in vitro, including growth in stromal cell co-cultures, adhesion to extracellular matrix molecules such as collagen I and fibronectin, and migration towards the chemotactic stimulus, SDF-1α. Receptor stimulation also led to augmented in vivo homing, CXCR4-mediated lodgment at the endosteal niche, and engraftment capabilities. These mechanisms by which stimulating the CaR dictates preferential localization of HSCs in the BM endosteal niche provide additional insights into the fundamental interrelationship between the stem cell and its niche. These studies also have implications in the area of clinical stem cell transplantation, where ex vivo modulation of the CaR may be envisioned as a strategy to enhance HSC engraftment in the BM.
Introduction
In the adult hematopoietic system, hematopoietic stem cells (HSCs) reside in a specific anatomic location in the bone marrow (BM) known as the stem cell niche 1 . The signaling cues originating from the stem cell niche serve as instructions for the HSCs to undergo either self-renewal or differentiation for the maintenance of the hematopoietic system in the individual. In the clinical transplantation setting, interactions between the transplanted HSCs and the stem cell niche are essential in determining the clinical outcome of the transplantation 2 . In order for successful engraftment and re-establishment of hematopoiesis to occur in the recipient, the transplanted HSCs must first migrate from the peripheral circulation to the BM, a process known as homing 3 , then adhere and be retained in the specialized niches within the BM, a process known as lodgment 4 . After lodgment, the specific fate of the transplanted HSCs is determined through complex, bi-directional interactions with various extrinsic components in the niche 5 .
The process of HSC lodgment following transplantation is believed to be regulated in part by cell adhesion molecules (CAMs) expressed on the cellular surface. Previous studies have demonstrated the importance of cell surface molecules such as α 4 integrins 6 , hyaluronic acid 7 , or stem cell factor 8 and osteopontin 9 in retaining HSCs in the BM endosteal region through interactions with stem cell niche components. However, studies on the identification of the molecules that dictate lodgment are complicated by the vast array of CAMs that are expressed on
HSCs and the broad range of potential ligands that are expressed on the stromal cells with possible overlapping functions 10 . Because the endosteal surface of the bone is known to have a high concentration of Ca 2+ ions that reaches as high as 40mM underneath resorbing osteoclasts 11 , we hypothesized that lodgment of HSC in the endosteal region of the BM is specifically dictated
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From by this unique feature. Our previous work has shown the role of the calcium-sensing receptor (CaR), a G-protein coupled receptor that plays a key role in the regulation of extracellular calcium homeostasis 12, 13 , in HSC lodgment and engraftment in the BM, where HSCs deficient for the CaR lose their ability to lodge at the endosteal surface of bone, leading to defective engraftment 14 .
In this study we wished to examine the precise cellular and molecular mechanisms that dictate
CaR-mediated HSC lodgment in the adult BM stem cell niche. By stimulating the activity of CaR using a CaR agonist, underlying mechanisms of HSC lodgment in the BM endosteal region following transplantation can be elucidated, providing additional insights for the fundamental interrelationship between the stem cell niche and stem cell fate. Cinacalcet, a calcimimetic compound clinically approved to be used as a treatment for secondary hyperparathyroidism, acts as a positive allosteric modulator of CaR to increase the sensitivity of the receptor to activation by extracellular Ca 2+ ions. This allows modulation of the functional CaR without altering the level of extracellular Ca 2+ concentration 15 . Apoptosis assay. BM MNCs were stained with lineage and stem cell antibodies, as described above. Treated cells were then stained with 7-Amino-Actinomycin (7-AAD) and PE Annexin V (both from BD Biosciences) according to manufacturer's instructions. Using an LSR II flow cytometer (BD), the percentage of apoptotic cells following treatment was determined as 7-AAD negative and PE Annexin V positive.
Quantitative RT-PCR. Total RNA was extracted using the RNA Miniprep Kit (Stratagene, La Jolla, CA, USA) and reverse-transcribed into cDNA using the SuperScript VILO cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's instructions.
To quantify the expression of car, cxcr4, and hprt1, Taqman Gene Expression Assays primers and probe sets (Applied Biosystems, Branchburg, New Jersey, USA and Roche Diagnostics, Mannheim, Germany) were used. Levels of gene expression were quantified using the 7900HT real-time PCR system (Applied Biosystems). Standard curves in these experiments were created using total mouse kidney RNA obtained from C57Bl/6 mice.
Adhesion molecule expression. BM MNCs were treated as described above, then stained with lineage and stem cell markers along with PE anti-mouse CXCR4 (BD Biosciences), CD49d, and Immunohistochemistry. Tibias were dissected from C57Bl/6 mice and fixed in 10% formalin overnight at 4°C. The bones were then decalcified with 20% EDTA over a two-week period and were processed and embedded in paraffin using standard histological procedures. Whole bone sections were cut at 5µm and incubated with anti-collagen I goal polyclonal IgG (Abcam, Cambridge, MA, USA) overnight at 4°C. Slides were then blotted with donkey-anti-goat secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 30 minutes at room temperature. The Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA) was applied to the slides and incubated for 30 minutes at room temperature. The slides were then rinsed with PBS-Tween, and Alkaline Phosphatase Vector Substrate was added to the blots. The slides were then incubated in the dark for 10 minutes. Upon color formation, the slides were rinsed with distilled water and then counterstained with Methyl Green. The slides were then cover-slipped using Cytoseal XYL mounting medium (Richard-Allan Scientific, Kalamazoo, MI, USA) and examined using a Nikon Eclipse 50i upright microscope. (Figure 2c ). Furthermore, CaR stimulation slightly enhanced LKS + F + cell adhesion to collagen I (Figure 2c ). In contrast, CaR stimulation significantly enhanced LKS -F + cell adhesion to fibronectin, but not to collagen I (p<0.01) (Figure 2c ). These results demonstrate that the effect of CaR stimulation was to augment cell adhesion specifically to collagen I or fibronectin, which was distinctive according to both the cell population and the ECM components expressed in the adult BM. However, it is important to note that adhesion to collagen I alone does not provide specificity in the localization of primitive hematopoietic cells in the endosteal region of the BM, as histological assessment showed that collagen I is expressed ubiquitously along the surface of the bone (Supplemental Figure S3) . Therefore, collagen I may only play a part in the specific localization of primitive hematopoietic cells in the endosteal niche.
In vivo homing. LK cells were sorted using a FACSAria flow cytometer (BD
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Cinacalcet treatment augments primitive hematopoietic cell activity in vivo.
We next wished to investigate the effects of CaR stimulation on hematopoietic stem and progenitor cell function in vivo using models of homing, lodgment, and engraftment. For our homing studies, purified LK cells were differentially labeled with fluorescent dyes to track the cells in vivo, and then treated with Cinacalcet or ethanol control. These cells were then co-injected into the same non-irradiated mouse recipient, and the frequency of cells homing to the BM and spleen was calculated using flow cytometric analysis. Our results showed CaR stimulation by Cinacalcet treatment led to a significant improvement in the ability of the injected cells to home to the BM (p<0.05) (Figure   3a ), and a slight improvement to the spleen (Figure 3b ). To test for the effect of different dyes on homing efficiency, we labeled the cells with either DiI or SNARF (red dyes) and DiO or CFSE (green dyes) and analyzed the number of homed cells in the recipient. We found that there was
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